Rare diseases
Investigational molecules
Locations
Back to Germany737 clinical trials in Heidelberg, Germany across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study to Test BI 765845 for Patients with Heart Attack
GermanyStudy of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer
GermanyStudy of Daratumumab Injection for Patients with High-Risk Smoldering Multiple Myeloma
GermanyStudy on Seralutinib for Treating Pulmonary Arterial Hypertension in Patients
GermanyStudy of Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone for Patients with Newly Diagnosed AL Amyloidosis with Heart Involvement
GermanyStudy on Larotrectinib for Treating Children with Advanced Solid Tumors with NTRK Fusion
GermanyStudy on Vilobelimab and Drug Combination for Treating Ulcerative Pyoderma Gangrenosum in Adults
GermanyStudy on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer
GermanyStudy of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma
GermanyStudy Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer
GermanyStudy on the Effects of Inhaled ETD001 for People with Cystic Fibrosis
GermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on heart failure prevention and treatment of TTR amyloidosis cardiovascular complications. Studies evaluating new therapeutic approaches for pulmonary hypertension.
Research includes evaluation of novel compounds for heart conditions and preventive therapies.
Comprehensive research in lung cancer, bladder cancer, and melanoma treatments. Advanced trials for various lymphomas and leukemias using innovative therapeutic approaches.
Focus on targeted therapies and immunological approaches in cancer treatment.
Groundbreaking research in kidney transplantation with innovative immune system modification approaches. Studies exploring new methods to improve transplant outcomes.
Emphasis on developing personalized immunosuppression strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
